Crossmark

Enhancing Data Quality in Clinical Trials: Cross-Company Validation of the Open-Source Clinical Trial Anomaly Spotter (CTAS)

Published Online: 2026-03-12

Published Print: 2026-05

Authors

Tiikkainen, Pekka

Collin, Frederik

Koneswarakantha, Björn
License Information

Text and Data Mining valid from 2026-03-12

Version of Record valid from 2026-03-12
More Information

Article History

Received: 3 September 2025

Accepted: 25 February 2026

First Online: 12 March 2026

Declarations

:

: The author’s have no competing interest to declare other than their employments. Pekka Tiikkainen: Bayer, Frederik Collin: Boehringer Ingelheim, Björn Koneswarakantha: Roche.

Document is current